Health in AMR 65 indicators covering health for AMR. IndicatorLatest Year10-yr change Rank Pertussis - number of reported cases 24,640 2025 down 23.3% 8th Total tetanus - number of reported cases 385 2025 down 32.2% 11th Infant mortality rate (probability of dying between birth and age 1) 10.91 2024 down 16.0% 10th Under-five mortality rate 12.64 2024 down 16.9% 11th Maternal mortality ratio 58.54 2023 up 2.0% 8th Number of deaths among adolescents 21,189 2024 down 3.3% 13th Number of deaths among children ages 5 to 9 years 15,663 2024 down 13.0% 13th Mortality rate among children ages 5 to 9 years 1.08 2024 down 8.5% 13th Population with primary reliance on polluting fuels and technologies 42.21 2023 down 24.2% 10th Population with primary reliance on clean fuels and technologies for 141.92 2023 up 4.4% 10th Proportion of population with primary reliance on polluting fuels and 22.9% 2023 down 21.1% 10th Proportion of population with primary reliance on fuels and 33.6% 2023 down 23.4% 8th Population with primary reliance on fuels and technologies for 37.18 2023 down 27.0% 10th Prevalence of diabetes, age-standardized 13.06 2022 up 19.0% 7th Prevalence of diabetes, crude 14.59 2022 up 27.2% 6th Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 92.0% 2025 down 5.2% 4th Measles-containing-vaccine first-dose (MCV1) immunization coverage 88.0% 2025 down 5.4% 9th New HIV infections 0.18 2025 unchanged 2nd BCG immunization coverage among 1-year-olds (%) 88.0% 2025 down 8.3% 9th Mean total cholesterol, crude 4.7 2018 down 2.1% 4th Mean total cholesterol, age-standardized 4.6 2018 down 4.2% 7th Mean HDL cholesterol, crude 1.2 2018 unchanged 6th Stunting numbers among children under 5 years of age (millions) 6,625 2024 down 6.6% 15th Stunting prevalence among children under 5 years of age (%) 9.9% 2024 up 4.2% 15th Overweight prevalence among children under 5 years of age (%) 9.1% 2024 up 16.7% 1st Overweight numbers among children under 5 years of age (thousands) 6,111 2024 up 5.2% 10th Adolescent mortality rate 1.27 2021 down 12.5% 8th Incidence of tuberculosis 33 2024 up 10.0% 13th Deaths due to tuberculosis among HIV-negative people 2.1 2024 up 16.7% 13th Domestic private health expenditure (PVT-D) as percentage of current 41.8% 2023 down 5.0% 9th Prevalence of HIV among adults aged 15 to 49 0.5% 2025 unchanged 4th Estimated number of people (all ages) living with HIV 4.30 million 2025 up 34.4% 4th Estimated antiretroviral therapy coverage among people living with HIV 71.0% 2025 up 31.5% 4th Hypertension among adults aged 30-79 years, prevalence, crude 37.5 2019 up 3.0% 3rd Hypertension: diagnosis coverage among adults aged 30-79 with 71.2% 2019 up 6.9% 2nd Hypertension: effective treatment coverage (controlled hypertension) 37.3% 2019 up 14.8% 2nd Hypertension treatment coverage among adults aged 30-79 with 62.0% 2019 up 7.3% 2nd Hypertension among adults aged 30-79 years, prevalence 35.4 2019 down 1.4% 4th Hypertension: diagnosis coverage among adults aged 30-79 with 69.8% 2019 up 5.3% 1st Number of new HIV infections 180,000 2025 unchanged 4th Births attended by skilled health personnel 97.0% 2025 up 1.0% 5th Inactivated first-dose polio vaccine (IPV1) immunization coverage 91.0% 2025 up 26.4% 6th Low birth weight number 1,272 2020 down 7.3% 15th Concentrations of fine particulate matter 14.3 2023 down 19.4% 15th Estimated number of MDR/RR-TB incident cases 14,000 2024 up 16.7% 12th Prevalence of anaemia in children aged 6-59 months 16.5% 2019 down 17.1% 15th Number of children aged 6-59 months with anaemia 12,070 2019 down 20.2% 13th Mean hemoglobin level of children aged 6-59 months 121 2019 up 0.8% 1st Hepatitis B surface antigen (HBsAg) prevalence 0.0% 2024 down 100.0% 12th Number of deaths attributed to non-communicable diseases, by type of 1.36 million 2019 up 16.5% 11th Estimated number of malaria cases 663,364 2024 up 39.6% 10th Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 4th Estimated number of children needing antiretroviral therapy based on 36,000 2025 down 29.4% 6th Estimated antiretroviral therapy coverage among children 48 2025 up 20.0% 6th HPV immunization coverage estimates among primary target cohort (9-14) 71.0% 2025 up 24.6% 1st Smear-positive tuberculosis treatment-success rate 78.0% 2011 up 13.0% 12th Number of indigenous P. falciparum malaria cases 96,008 2021 down 6.1% 10th Number of suspected malaria cases 5.21 million 2021 down 22.8% 10th Number of malaria positive cases by microscopy 328,483 2021 down 23.5% 6th Number of malaria suspects examined by microscopy 4.42 million 2021 down 31.6% 8th Page 1 of 2 Next →